A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
This study has been completed.
First Posted: December 17, 2008
Last Update Posted: October 12, 2015
Information provided by (Responsible Party):